CONMED (CNMD) Competitors

Stevanato Group (NYSE:STVN) and CONMED (NYSE:CNMD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, community ranking, dividends and earnings.

Is STVN or CNMD more profitable?

Stevanato Group has a net margin of 10.47% compared to CONMED's net margin of 10.13%. CONMED's return on equity of 14.31% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	10.47%	9.86%	5.79%
CONMED	10.13%	14.31%	5.64%

Which has more risk & volatility, STVN or CNMD?

Stevanato Group has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500.

Does the MarketBeat Community prefer STVN or CNMD?

CONMED received 6 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 63.27% of users gave Stevanato Group an outperform vote while only 45.68% of users gave CONMED an outperform vote.

Company	Underperform	Outperform
Stevanato Group	Outperform Votes 31 63.27%	Underperform Votes 18 36.73%
CONMED	Outperform Votes 37 45.68%	Underperform Votes 44 54.32%

Do analysts prefer STVN or CNMD?

CONMED has a consensus target price of $62.20, suggesting a potential upside of 4.82%. Given CONMED's higher possible upside, analysts plainly believe CONMED is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
CONMED	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Is STVN or CNMD a better dividend stock?

Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.2%. CONMED pays an annual dividend of $0.80 per share and has a dividend yield of 1.3%. Stevanato Group pays out 11.8% of its earnings in the form of a dividend. CONMED pays out 21.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stevanato Group has increased its dividend for 1 consecutive years.

Which has better earnings and valuation, STVN or CNMD?

Stevanato Group has higher earnings, but lower revenue than CONMED. CONMED is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	$1.12B	6.50	$157.62M	$0.51	47.31
CONMED	$1.32B	1.40	$132.42M	$3.80	15.62

Does the media favor STVN or CNMD?

In the previous week, Stevanato Group had 6 more articles in the media than CONMED. MarketBeat recorded 7 mentions for Stevanato Group and 1 mentions for CONMED. Stevanato Group's average media sentiment score of 1.03 beat CONMED's score of 0.96 indicating that Stevanato Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Stevanato Group beats CONMED on 13 of the 20 factors compared between the two stocks.